Zenas Biopharma Inc

Insider buying surge at Zenas Biopharma shows modest yet consistent confidence, tied to a 21% weekly gain, analyst upgrades and strong social‑media buzz—watch the pipeline for upside.

Insider buying surges at Zenas Biopharma, boosting confidence in its immunology pipeline and potential pricing strategy – see how this could shape investors’ next move.

CEO insider buying fuels optimism for Zenas Biopharma’s volatile stock – a calculated 100k‑share spree that signals confidence amid clinical‑trial uncertainty.